Advertisement

HIV/AIDS

FDA OKs Injectable Cabotegravir for HIV PrEP

Injectable option lets patients forego daily pill The FDA approved an extended-release injectable version of cabotegravir (Apretude) as pre-exposure prophylaxis (PrEP) for adults and adolescents weighing at least 35 kg (77 lbs)...

Read More

For latest news and updates
Email-id is invalid